APASL Oncology 2022 (APASL STC in Takamatsu).

APASL Oncology 2022 (APASL STC in Takamatsu)

Industry / Supported Symposium

Day 1: September 1 (Thursday) 2022

Luncheon Seminar 1 Sponsored by Chugai Pharmaceutical Co., Ltd.

12:30-13:30 (JST)Room 1
Chair: Dr. Kiyoshi Hasegawa (Japan)

Future Prospects for Hepatocellular Carcinoma Treatment Through Immune Control
Dr. Nobuhiro Nakamoto (Japan)
Recent Advances in Systemic Therapy for Unresectable Hepatocellular Carcinoma ~Atezolizumab Plus Bevacizumab Therapy in Real-world Practice~
Dr. Kaoru Tsuchiya (Japan)

Luncheon Seminar 2 Sponsored by Gilead Sciences K.K.

12:30-13:30 (JST)Room 2
Chair: Dr. Norifumi Kawada (Japan)

Role of Medical AI for the Management of Liver Disease in the Era of Viral Elimination
Dr. Naoshi Nishida (Japan)

Day 2: September 2 (Friday) 2022

Morning Seminar 1Sponsored by Otsuka Pharmaceutical Co., Ltd.

8:00-9:00 (JST)Room 1
Chair: Dr. Koichi Takaguchi (Japan)

Total Therapeutic Management of Liver Disease
Dr. Atsushi Hiraoka (Japan)
Real-world Evidences of Systemic Therapy for Hepatocellular Carcinoma
Dr. Masayuki Kurosaki (Japan)

Luncheon Seminar 3 Sponsored by AbbVie GK

12:30-13:30 (JST)Room 1
Chair: Dr. Hitoshi Yoshiji (Japan)

Real-word Direct-acting Antivirals Treatment for Chronic Hepatitis C Patients with Chronic Kidney Disease in Japan
Dr. Masanori Atsukawa (Japan)

Morning Seminar 2Sponsored by Asahi Kasei Pharma Corporation

8:00-9:00 (JST)Room 2
Chair: Dr. Keiichi Okano (Japan)

Treatment Strategies for Acute Cholangitis
Dr. Hideki Kamada (Japan)

Luncheon Seminar 4 Sponsored by Eisai Co., Ltd. / MSD K.K.

12:30-13:30 (JST)Room 2
Chair: Dr. Junji Furuse (Japan)

Value of LEN + IVR Therapy in the Treatment of HCC Based on Clinical Practice
Dr. Hideki Iwamoto (Japan)
The Dawn of New Surgical Strategy for Advanced Hepatocellular Carcinoma
Dr. Junichi Shindoh (Japan)

Day 3: September 3 (Saturday) 2022

Morning Seminar 3 Sponsored by AI Medical Service Inc.

8:00-9:00 (JST)Room 1
Chair: Dr. Kiyoshi Hasegawa (Japan)
“The Impact of AI on Tomorrow’s Endoscopic Medicine”

Current Status and Future of AI in Digestive Disease
Dr. Yuzo Kodama (Japan)
Taking on the World with Japanese Endoscopic AI
Dr. Tomohiro Tada (Japan)

Special Comment Dr. Tetsuji Takayama (Japan)

Morning Seminar 4 Sponsored by Takeda Pharmaceutical Co., Ltd.

8:00-9:00 (JST)Room 2
Chair: Dr. Makoto Oryu (Japan)

Positioning of Vonoprazan and Its Safety - Seven Years of Clinical Experience in Japan
Dr. Ken Haruma (Japan)